With over 80 years of use, the safety of aluminum adjuvants used in vaccines continues to rest on assumptions rather than scientific evidence. To date, a minimal amount of scientific evidence or research has been conducted regarding the safety of vaccines and the ingredients that come with them. That being said, recent research has shown pediatric populations suffer from unknown adverse reactions that stem from the toxicity of aluminum adjuvants.
Evidence that is available draws the conclusion that long-term persistence of aluminum adjuvants in adults can lead to cognitive dysfunction and autoimmunity. This raises the question – how does its use affect developing children? Since children and adults receive the same vaccines with the same dosage, children continue to be regularly exposed to much higher levels of aluminum adjuvants than adults because of their smaller and unique body structure.
Christopher Shaw and Lucija Tomljenovic are funded researchers of Children’s Medical Safety Research Institute and have drawn concerns regarding the use of neurotoxic substances such as aluminum as an adjuvant in pediatric vaccine formulations. The researchers urge that infants and young children should not be considered “small adults” when it comes to toxicological risks. The use of the same vaccinations should cease because children are not fully developed. The inherent risks pose developmental concerns when injecting the aluminum adjuvants because it can manipulate the autoimmune system in negative ways.
They suggest that aluminum vaccines cause multifactorial stimulatory effects on the immune system that can result in antigenic compounds failure to launch adequate immune responses. Also, during prenatal and early postnatal development, the brain is extremely vulnerable to neurotoxic insults. The development is highly sensitive and exposure to the neurotoxins will have a permeable impact to vital living functions. In addition to the early developmental stages of children and infants, ‘the immature renal system of the neonates significantly compromises their ability to eliminate environmental toxicants.’
This research should be enough evidence that children are at a higher risk of adverse reactions from aluminum adjuvants than adults. Infants and children have a unique physiology compared to adults that makes them much more vulnerable to noxious environmental insults.